Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology
for
Central Nervous System Neoplasm, Leptomeningeal Neoplasm,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT04988009
Recruiting
Cognitive Impairment in Colorectal Cancer Patients Receiving Cytotoxic Chemotherapy
for
Neoplasm, Colorectal, Cognitive Impairment,
Location: Fort Wayne IN
Sponsor: Joseph McCollom
Sex: All
Age: 18+
Code: NCT05014399
Recruiting
Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer
for
Breast Cancer, Brain Metastases
Location: New York NY
Sponsor: Weill Medical College of Cornell University
Sex: Female
Age: 18+
Code: NCT06072807
Recruiting
Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System
for
Central Nervous System Neoplasm, Cranial Nerve Disorder,
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute
Sex: All
Age: 10+
Code: NCT03270059
Phase2, Recruiting
Molecular Basis of Pediatric Liver Cancer
for
Childhood Liver Cancer, Liver Malignant Tumors,
Location: Pittsburgh PA
Sponsor: University of Pittsburgh
Sex: All
Age: 0 - 70+
Code: NCT03959800
Recruiting
Multitracer [18F]Fluciclovine and 18F-FDG PET, and Advanced MRI for Metabolic Profiling of Glioblastoma
for
Glioblastoma, Recurrent Glioblastoma,
Location: Philadelphia PA
Sponsor: Abramson Cancer Center at Penn Medicine
Sex: All
Age: 18+
Code: NCT06613841
Early_phase1, Recruiting
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
for
Acral Lentiginous Melanoma,
Location: Jacksonville NC, Goldsboro NC, Clinton NC,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT04511013
Phase2, Recruiting
MRI Screening for Brain Metastases Among Patients With Triple Negative or HER2+ Stage II or III Breast Cancer
for
Breast Cancer
Location: Toronto
Sponsor: Sunnybrook Health Sciences Centre
Sex: All
Age: 18+
Code: NCT06247449
Recruiting
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors